Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Buy" from Analysts

Key Points

• Cellebrite DI Ltd. (NASDAQ:CLBT) has received an average recommendation of "Buy" from analysts, with a target price of $22.40 over the next 12 months.
• Several institutional investors have increased their stakes in Cellebrite DI, including Northern Trust Corp, which lifted its position by 113.6% in the last quarter.
• Cellebrite DI reported earnings of $0.12 per share for the last quarter, surpassing analysts' expectations, with revenue growth of 18.4% year-over-year.

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) have received an average rating of "Buy" from the five ratings firms that are currently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $22.40.

CLBT has been the topic of several recent analyst reports. Lake Street Capital reduced their target price on Cellebrite DI from $24.00 to $22.00 and set a "buy" rating on the stock in a report on Friday, August 15th. Needham & Company LLC decreased their target price on Cellebrite DI from $24.00 to $18.00 and set a "buy" rating for the company in a research report on Thursday, August 14th. Finally, Wall Street Zen downgraded Cellebrite DI from a "buy" rating to a "hold" rating in a research note on Saturday.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Northern Trust Corp lifted its stake in shares of Cellebrite DI by 113.6% in the 4th quarter. Northern Trust Corp now owns 211,994 shares of the company's stock valued at $4,670,000 after purchasing an additional 112,731 shares during the last quarter. Bank of America Corp DE boosted its position in Cellebrite DI by 32.0% in the fourth quarter. Bank of America Corp DE now owns 680,375 shares of the company's stock valued at $14,989,000 after buying an additional 165,116 shares during the last quarter. Nuveen Asset Management LLC boosted its stake in shares of Cellebrite DI by 38.5% in the fourth quarter. Nuveen Asset Management LLC now owns 585,839 shares of the company's stock worth $12,906,000 after buying an additional 162,886 shares during the last quarter. Man Group plc purchased a new stake in shares of Cellebrite DI in the fourth quarter valued at approximately $2,385,000. Finally, Silvercrest Asset Management Group LLC acquired a new stake in Cellebrite DI during the 4th quarter worth $4,583,000. 45.88% of the stock is owned by hedge funds and other institutional investors.

Cellebrite DI Trading Down 2.2%

Cellebrite DI stock opened at $16.80 on Friday. Cellebrite DI has a 52 week low of $13.10 and a 52 week high of $26.30. The stock has a fifty day moving average price of $15.18 and a 200 day moving average price of $16.96. The firm has a market capitalization of $4.02 billion, a P/E ratio of -22.11, a PEG ratio of 3.12 and a beta of 1.28.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The company had revenue of $113.28 million for the quarter, compared to analysts' expectations of $112.33 million. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. The firm's revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.10 earnings per share. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts predict that Cellebrite DI will post 0.3 EPS for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.